S
Sarah J. Nelson
Researcher at University of California, San Francisco
Publications - 292
Citations - 24417
Sarah J. Nelson is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Magnetic resonance spectroscopic imaging & Magnetic resonance imaging. The author has an hindex of 86, co-authored 291 publications receiving 22507 citations. Previous affiliations of Sarah J. Nelson include University of California & University of California, Berkeley.
Papers
More filters
Journal ArticleDOI
Dynamic hyperpolarized carbon-13 MR metabolic imaging of nonhuman primate brain.
Ilwoo Park,Peder E. Z. Larson,James Tropp,Lucas Carvajal,Galen D. Reed,Robert Bok,Fraser Robb,John Bringas,Adrian P. Kells,Philip Pivirotto,Krystof S. Bankiewicz,Daniel B. Vigneron,Sarah J. Nelson +12 more
TL;DR: To investigate hyperpolarized 13C metabolic imaging methods in the primate brain that can be translated into future clinical trials for patients with brain cancer.
Journal ArticleDOI
Challenges in dynamic contrast‐enhanced MRI imaging of cervical lymph nodes to detect metastatic disease
Susan M. Noworolski,Nancy J. Fischbein,Michael J. Kaplan,Ying Lu,Sarah J. Nelson,Lucas Carvajal,Roland G. Henry +6 more
TL;DR: To identify and overcome challenges in using dynamic contrast‐enhanced magnetic resonance imaging (MRI) to distinguish tumor from nontumor in the cervical lymph nodes of patients with squamous cell carcinoma of the head and neck.
Journal ArticleDOI
Advances in ultra-high field MRI for the clinical management of patients with brain tumors.
TL;DR: Although progress has been limited by technical challenges, initial experience has demonstrated the promise of 7-T MRI in advancing existing paradigms for diagnosing, monitoring, and managing patients with brain tumors.
Journal ArticleDOI
Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab.
Qiuting Wen,Laleh Jalilian,Janine M. Lupo,Annette M. Molinaro,Susan M. Chang,Jennifer Clarke,Michael D. Prados,Sarah J. Nelson +7 more
TL;DR: The value of ADC metrics obtained from the T2L at the post-RT time point is emphasized as non-invasive biomarkers for assessing residual tumor in patients with newly diagnosed GBM being treated with combination therapy that includes the anti-angiogenic agent bevacizumab.
Journal ArticleDOI
Detection of localized changes in the metabolism of hyperpolarized gluconeogenic precursors 13 C-lactate and 13 C-pyruvate in kidney and liver.
Cornelius von Morze,Gene-Yuan Chang,Peder E. Z. Larson,Hong Shang,Prasanna K.R. Allu,Robert Bok,Jason C. Crane,Marram P. Olson,Chou T. Tan,Irene Marco-Rius,Sarah J. Nelson,John Kurhanewicz,David A. Pearce,Daniel B. Vigneron +13 more
TL;DR: The purpose of this study was to characterize tissue‐specific alterations in metabolism of hyperpolarized (HP) gluconeogenic precursors 13C‐lactate and 13C-pyruvate by rat liver and kidneys under conditions of fasting or insulin‐deprived diabetes.